Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald S Go

Showing results (231-240 of 402) with videos related to

Pageof 41
Sort By:
American Journal of Hematology|October 16, 2019
Hematopoietic score predicts outcomes in newly diagnosed multiple myeloma patientsAbdullah S Al Saleh, M Hasib Sidiqi, Angela Dispenzieri, et al.
Blood Cancer Journal|June 17, 2020
A population-based study of chronic neutrophilic leukemia in the United StatesGordon J Ruan, Caleb J Smith, Courtney Day, et al.
American Journal of Hematology|January 3, 2022
Impact of achieving a complete response to initial therapy of multiple myeloma and predictors of subsequent outcomeMarcella Kaddoura, Moritz Binder, David Dingli, et al.
Leukemia|November 28, 2019
Revisiting complete response in light chain amyloidosisSurbhi Sidana, Angela Dispenzieri, David L Murray, et al.
Leukemia & Lymphoma|October 15, 2020
Treatment facility volume and patient outcomes in Waldenstrom macroglobulinemiaMadugodaralalage D S K Gunaratne, Alexander J Sahakian, Jithma P Abeykoon, et al.
American Journal of Hematology|February 4, 2016
Clinical characteristics and outcomes in biclonal gammopathiesTrey C Mullikin, S Vincent Rajkumar, Angela Dispenzieri, et al.
British Journal of Haematology|August 26, 2022
Classical and non-classical phenotypes of Erdheim-Chester disease: Correlating clinical, radiographic and genotypic findingsAntonious Z Hazim, Aldo A Acosta-Medina, Jason R Young, et al.
Leukemia|February 11, 2025
Efficacy of MEK inhibitors in Erdheim-Chester disease: impact of MAPK pathway pathogenic variantsAldo A Acosta-Medina, Jithma P Abeykoon, Saurabh Zanwar, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 15, 2016
Myelomatous Involvement of the Central Nervous SystemJonas Paludo, Utkarsh Painuly, Shaji Kumar, et al.
Blood|March 10, 2022
International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adultsGaurav Goyal, Abdellatif Tazi, Ronald S Go, et al.
Pageof 41

Showing results (231-240 of 402) with videos related to

Sort By:
Pageof 41
American Journal of Hematology|October 16, 2019
Hematopoietic score predicts outcomes in newly diagnosed multiple myeloma patientsAbdullah S Al Saleh, M Hasib Sidiqi, Angela Dispenzieri, et al.
Blood Cancer Journal|June 17, 2020
A population-based study of chronic neutrophilic leukemia in the United StatesGordon J Ruan, Caleb J Smith, Courtney Day, et al.
American Journal of Hematology|January 3, 2022
Impact of achieving a complete response to initial therapy of multiple myeloma and predictors of subsequent outcomeMarcella Kaddoura, Moritz Binder, David Dingli, et al.
Leukemia|November 28, 2019
Revisiting complete response in light chain amyloidosisSurbhi Sidana, Angela Dispenzieri, David L Murray, et al.
Leukemia & Lymphoma|October 15, 2020
Treatment facility volume and patient outcomes in Waldenstrom macroglobulinemiaMadugodaralalage D S K Gunaratne, Alexander J Sahakian, Jithma P Abeykoon, et al.
American Journal of Hematology|February 4, 2016
Clinical characteristics and outcomes in biclonal gammopathiesTrey C Mullikin, S Vincent Rajkumar, Angela Dispenzieri, et al.
British Journal of Haematology|August 26, 2022
Classical and non-classical phenotypes of Erdheim-Chester disease: Correlating clinical, radiographic and genotypic findingsAntonious Z Hazim, Aldo A Acosta-Medina, Jason R Young, et al.
Leukemia|February 11, 2025
Efficacy of MEK inhibitors in Erdheim-Chester disease: impact of MAPK pathway pathogenic variantsAldo A Acosta-Medina, Jithma P Abeykoon, Saurabh Zanwar, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 15, 2016
Myelomatous Involvement of the Central Nervous SystemJonas Paludo, Utkarsh Painuly, Shaji Kumar, et al.
Blood|March 10, 2022
International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adultsGaurav Goyal, Abdellatif Tazi, Ronald S Go, et al.
Pageof 41